174 related articles for article (PubMed ID: 19148563)
21. The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover.
Frost ML; Cook GJ; Blake GM; Marsden PK; Fogelman I
J Clin Densitom; 2007; 10(1):46-54. PubMed ID: 17289526
[TBL] [Abstract][Full Text] [Related]
22. Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis.
Tran BN; Nguyen ND; Eisman JA; Nguyen TV
BMC Med Genet; 2008 Jun; 9():55. PubMed ID: 18588671
[TBL] [Abstract][Full Text] [Related]
23. A haplotype-based analysis of the LRP5 gene in relation to osteoporosis phenotypes in Spanish postmenopausal women.
Agueda L; Bustamante M; Jurado S; Garcia-Giralt N; Ciria M; Saló G; Carreras R; Nogués X; Mellibovsky L; Díez-Pérez A; Grinberg D; Balcells S
J Bone Miner Res; 2008 Dec; 23(12):1954-63. PubMed ID: 18684085
[TBL] [Abstract][Full Text] [Related]
24. No association between hip geometry and four common polymorphisms associated with fracture: the Danish osteoporosis prevention study.
Nissen N; Madsen JS; Bladbjerg EM; Beck Jensen JE; Jørgensen NR; Langdahl B; Abrahamsen B; Brixen K
Calcif Tissue Int; 2009 Apr; 84(4):276-85. PubMed ID: 19225709
[TBL] [Abstract][Full Text] [Related]
25. Genetic and environmental determinants of bone mineral density in Chinese women.
Lau HH; Ng MY; Ho AY; Luk KD; Kung AW
Bone; 2005 Apr; 36(4):700-9. PubMed ID: 15781005
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
[TBL] [Abstract][Full Text] [Related]
27. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women.
Bollerslev J; Wilson SG; Dick IM; Islam FM; Ueland T; Palmer L; Devine A; Prince RL
Bone; 2005 Apr; 36(4):599-606. PubMed ID: 15777745
[TBL] [Abstract][Full Text] [Related]
28. Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.
Van Poznak C; Hannon RA; Mackey JR; Campone M; Apffelstaedt JP; Clack G; Barlow D; Makris A; Eastell R
J Clin Oncol; 2010 Feb; 28(6):967-75. PubMed ID: 20065185
[TBL] [Abstract][Full Text] [Related]
29. LRP5 gene polymorphisms and idiopathic osteoporosis in men.
Ferrari SL; Deutsch S; Baudoin C; Cohen-Solal M; Ostertag A; Antonarakis SE; Rizzoli R; de Vernejoul MC
Bone; 2005 Dec; 37(6):770-5. PubMed ID: 16168727
[TBL] [Abstract][Full Text] [Related]
30. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Cohen S; Levy RM; Keller M; Boling E; Emkey RD; Greenwald M; Zizic TM; Wallach S; Sewell KL; Lukert BP; Axelrod DW; Chines AA
Arthritis Rheum; 1999 Nov; 42(11):2309-18. PubMed ID: 10555025
[TBL] [Abstract][Full Text] [Related]
31. A common LRP4 haplotype is associated with bone mineral density and hip geometry in men-data from the Odense Androgen Study (OAS).
Boudin E; Steenackers E; de Freitas F; Nielsen TL; Andersen M; Brixen K; Van Hul W; Piters E
Bone; 2013 Apr; 53(2):414-20. PubMed ID: 23321396
[TBL] [Abstract][Full Text] [Related]
32. Association between the A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene and bone mineral density: a meta-analysis.
Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
Rheumatol Int; 2009 Mar; 29(5):539-44. PubMed ID: 18932002
[TBL] [Abstract][Full Text] [Related]
33. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
34. Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication.
Riancho JA; Olmos JM; Pineda B; García-Ibarbia C; Pérez-Núñez MI; Nan DN; Velasco J; Cano A; García-Pérez MA; Zarrabeitia MT; González-Macías J
Eur J Endocrinol; 2011 Jan; 164(1):123-31. PubMed ID: 20926594
[TBL] [Abstract][Full Text] [Related]
35. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study.
Ferrari SL; Karasik D; Liu J; Karamohamed S; Herbert AG; Cupples LA; Kiel DP
J Bone Miner Res; 2004 Apr; 19(4):552-9. PubMed ID: 15005841
[TBL] [Abstract][Full Text] [Related]
36. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
Boonen S; Klemes AB; Zhou X; Lindsay R
J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
[TBL] [Abstract][Full Text] [Related]
38. Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study.
Guadalix S; Martínez-Díaz-Guerra G; Lora D; Vargas C; Gómez-Juaristi M; Cobaleda B; González EM; Hawkins F
Transpl Int; 2011 Jul; 24(7):657-65. PubMed ID: 21466595
[TBL] [Abstract][Full Text] [Related]
39. [Association of polymorphism of low density lipoprotein receptor-related protein 5 Q89R, A1330V with bone mineral density in premenopausal northern Chinese women].
Li Y; Sun CH; Yin H; Chen YF
Wei Sheng Yan Jiu; 2006 Sep; 35(5):576-9. PubMed ID: 17086708
[TBL] [Abstract][Full Text] [Related]
40. Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men.
Koh JM; Jung MH; Hong JS; Park HJ; Chang JS; Shin HD; Kim SY; Kim GS
J Korean Med Sci; 2004 Jun; 19(3):407-12. PubMed ID: 15201508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
